Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
CDC’s website is being modified to comply with President Trump’s Executive Orders.
Volume 13, Number 8—August 2007
Research

Venezuelan Equine Encephalitis Virus Infection of Cotton Rats

Anne-Sophie Carrara*, Lark L. Coffey*, Patricia V. Aguilar*, Abelardo C. Moncayo*, Amelia P.A. Travassos Da Rosa*, Marcio R.T. Nunes†, Robert B. Tesh*, and Nikos Vasilakis*Comments to Author 
Author affiliations: *University of Texas Medical Branch, Galveston, Texas, USA; †Evandro Chagas Institute, Belém, Brazil;

Main Article

Figure 5

Antibody responses in cotton rats from Florida and Texas. A) Neutralizing antibody (NAb) titers in Florida group (n = 3–11) and Texas group (n = 1–17) inoculated with subtypes IE or ID Venezuelan equine encephalitis virus (VEEV). B) Long-term NAb titers in Florida rats infected with subtype IE VEEV (n = 2). C) Hemagglutination inhibition (HI) antibody titers for Florida (n = 2–10) and Texas (n = 1–16) rats inoculated with subtype IE VEEV. D) Immunoglobulin M antibody titers for Florida and Texas rats infected with subtype IE VEEV (n = 2). OD, optical density.

Figure 5. Antibody responses in cotton rats from Florida and Texas. A) Neutralizing antibody (NAb) titers in Florida group (n = 3–11) and Texas group (n = 1–17) inoculated with subtypes IE or ID Venezuelan equine encephalitis virus (VEEV). B) Long-term NAb titers in Florida rats infected with subtype IE VEEV (n = 2). C) Hemagglutination inhibition (HI) antibody titers for Florida (n = 2–10) and Texas (n = 1–16) rats inoculated with subtype IE VEEV. D) Immunoglobulin M antibody titers for Florida and Texas rats infected with subtype IE VEEV (n = 2). OD, optical density.

Main Article

Page created: June 30, 2010
Page updated: June 30, 2010
Page reviewed: June 30, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external